Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-09-26

FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental application for amantadine hydrochloride, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine hydrochloride (amantadine hydrochloride)

Snippet

SUPPL AP for AMANTADINE HYDROCHLORIDE (AMANTADINE HYDROCHLORIDE)